Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided liver tumour-directed procedures, play a leading part in the management of 50–60% of HCCs. Radiofrequency is the mainstay for local ablation at early stages and transarte...
Alternative Titles
Full title
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2483813105
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2483813105
Other Identifiers
ISSN
1759-5045
E-ISSN
1759-5053
DOI
10.1038/s41575-020-00395-0
